Literature DB >> 15120215

Giant pituitary tumors: a study based on surgical treatment of 118 cases.

Atul Goel1, Trimurti Nadkarni, Dattatraya Muzumdar, Ketan Desai, Umesh Phalke, Praveen Sharma.   

Abstract

BACKGROUND: The aim of the study is to analyze the nature, extensions, and dural relationships of hormonally inactive giant pituitary tumors. The relevance of the anatomic relationships to surgery is analyzed.
METHODS: There were 118 cases of hormonally inactive pituitary tumors analyzed with the maximum dimension of more than 4 cm. These cases were surgically treated in our neurosurgical department from 1995 to 2002. Depending on the anatomic extensions and the nature of their meningeal coverings, these tumors were divided into 4 grades. The grades reflected an increasing order of invasiveness of adjacent dural and arachnoidal compartments. The strategy and outcome of surgery and radiotherapy was analyzed for these 4 groups. Average duration of follow-up was 31 months.
RESULTS: There were 54 giant pituitary tumors, which remained within the confines of sellar dura and under the diaphragma sellae and did not enter into the compartment of cavernous sinus (Grade I). Transgression of the medial wall and invasion into the compartment of the cavernous sinus (Grade II) was seen in 38 cases. Elevation of the dura of the superior wall of the cavernous sinus and extension of this elevation into various compartments of brain (Grade III) was observed in 24 cases. Supradiaphragmatic-subarachnoid extension (Grade IV) was seen in 2 patients. The majority of patients were treated by transsphenoidal route.
CONCLUSIONS: Giant pituitary tumors usually have a meningeal cover and extend into well-defined anatomic pathways. Radical surgery by a transsphenoidal route is indicated and possible in Grade I-III pituitary tumors. Such a strategy offers a reasonable opportunity for recovery in vision and a satisfactory postoperative and long-term outcome. Biopsy of the tumor followed by radiotherapy could be suitable for Grade IV pituitary tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15120215     DOI: 10.1016/j.surneu.2003.08.036

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  39 in total

1.  The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas.

Authors:  Lubin Qiu; Dongsheng He; Xiang Fan; Zhi Li; Chuangxin Liao; Yonghong Zhu; Haijun Wang
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

2.  The clinical significance of MIB-1 labeling index in pituitary adenomas.

Authors:  Geeta Chacko; Ari G Chacko; Kalman Kovacs; Bernd W Scheithauer; Sunithi Mani; J P Muliyil; M S Seshadri
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

3.  The current role of transcranial surgery in the management of pituitary adenomas.

Authors:  Ravindran Pratheesh; Simon Rajaratnam; Krishna Prabhu; Sunithi E Mani; Geeta Chacko; Ari G Chacko
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

4.  Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery.

Authors:  Christoph P Hofstetter; Michael J Nanaszko; Lynn L Mubita; John Tsiouris; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 5.  Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas.

Authors:  Ricardo J Komotar; Robert M Starke; Daniel M S Raper; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

6.  Pediatric giant pituitary adenomas: are they different from adults? A clinical analysis of a series of 12 patients.

Authors:  Sumit Sinha; Avijit Sarkari; A K Mahapatra; B S Sharma
Journal:  Childs Nerv Syst       Date:  2014-04-29       Impact factor: 1.475

7.  Predictive factors for vision recovery after optic nerve decompression for chronic compressive neuropathy: systematic review and meta-analysis.

Authors:  Andrew P Carlson; Martina Stippler; Orrin Myers
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-26

Review 8.  Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.

Authors:  Pedro Iglesias; Víctor Rodríguez Berrocal; Juan José Díez
Journal:  Endocrine       Date:  2018-06-16       Impact factor: 3.633

9.  Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors.

Authors:  Nader Sanai; Alfredo Quiñones-Hinojosa; Jared Narvid; Sandeep Kunwar
Journal:  J Neurooncol       Date:  2007-12-19       Impact factor: 4.130

10.  The role of the le fort I maxillotomy in the management of incompletely resected pituitary macroadenomas.

Authors:  Bruce Mickey; Leslie Hutchins; Edward Ellis
Journal:  Skull Base       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.